In a 68-year-old female who underwent left nephrectomy yesterday for a large renal mass, with a preoperative urine culture showing no growth, who is afebrile but has leukocytosis (white blood cell count 26 ×10⁹/L, neutrophils 87.5%) and has been receiving Piperacillin‑Tazobactam (broad‑spectrum antibiotic) for 5 days, is the leukocytosis likely a malignancy‑related finding, and should the antibiotic regimen be changed?

Post-Nephrectomy Leukocytosis Management

The elevated WBC count (26 ×10⁹/L with 87.5% neutrophils) one day post-nephrectomy is most likely a normal surgical stress response, not infection or paraneoplastic syndrome—continue current Piperacillin-Tazobactam without modification and monitor clinical trajectory.

Clinical Context Analysis

Your patient presents with marked leukocytosis in the immediate postoperative period following major oncologic surgery. This clinical picture requires systematic evaluation:

Expected Postoperative Leukocytosis

• Surgical stress alone can double the peripheral WBC count within hours due to mobilization of bone marrow storage pools and demargination of intravascular neutrophils 1
• Major surgery, trauma, and physiologic stress are well-established noninfectious causes of acute leukocytosis 1
• The timing (24 hours post-nephrectomy) strongly suggests a physiologic stress response rather than infection

Infection Unlikely

Your patient has multiple reassuring features against active infection:

• Afebrile with no chills
• Preoperative urine culture showed no growth
• Already receiving appropriate broad-spectrum coverage with Piperacillin-Tazobactam for 5 days
• No clinical signs of sepsis or hemodynamic instability

The absence of fever is particularly important. While leukocytosis can indicate infection, persistent fever alone in a clinically stable patient is rarely an indication to alter antibiotic regimen 2. Your patient doesn't even have fever.

Paraneoplastic Syndrome Consideration

Paraneoplastic leukocytosis from renal cell carcinoma typically:

• Presents preoperatively (the tumor is now removed)
• Persists chronically rather than appearing acutely postoperatively
• Would not explain the timing of leukocytosis appearing immediately after surgery

Antibiotic Management Recommendations

Continue Current Regimen

Do not change antibiotics at this time. The evidence strongly supports maintaining your current approach:

• Piperacillin-Tazobactam provides appropriate broad-spectrum coverage for postoperative prophylaxis in urologic surgery 3
• Specific antimicrobial changes should be guided by clinical deterioration or culture results, not by fever pattern or WBC count alone 2
• For patients who are clinically stable (like yours), continue initial antibacterial therapy 4

Duration of Prophylaxis

Standard surgical prophylaxis guidelines indicate:

• Single preoperative dose is typically sufficient for nephrectomy in low-risk patients 3
• Your patient has already received 5 days of therapy, which exceeds standard prophylaxis
• Consider discontinuing antibiotics if patient remains afebrile and clinically stable over the next 24-48 hours, as prolonged unnecessary antibiotic use increases risks of Clostridioides difficile infection 5, 6 and drug-related toxicity

Critical Monitoring Parameters

Hematologic Surveillance

Important caveat: Piperacillin-Tazobactam itself can cause leukopenia/neutropenia, particularly with prolonged administration (≥21 days) 7. However:

• This typically manifests as decreasing WBC counts, not leukocytosis
• Most commonly occurs after 15+ days of therapy 8
• Your patient is only on day 5

Monitor complete blood count daily to assess trajectory:

• Rising WBC: Suggests ongoing surgical stress response (expected to peak days 1-3, then normalize)
• Stable elevated WBC: Continue observation if clinically well
• Falling WBC: Consider drug-induced neutropenia if prolonged therapy continues 7, 9

Clinical Reassessment at 48-72 Hours Post-Op

Evaluate for:

• Temperature trends: Persistent or new fever would warrant investigation
• Wound examination: Signs of surgical site infection
• Respiratory status: Postoperative pneumonia
• Urinary symptoms: Though preop culture was negative
• Hemodynamic stability: Sepsis indicators

If any clinical deterioration occurs, obtain:

• Repeat blood cultures
• Wound cultures if drainage present
• Chest imaging if respiratory symptoms
• Urinalysis and culture

Specific Algorithm for Decision-Making

Day 1-2 Post-Op (Current Status):

• Continue Piperacillin-Tazobactam
• Monitor CBC daily
• Observe for fever or clinical signs of infection

Day 3-5 Post-Op:

• If afebrile, clinically stable, WBC trending down → Discontinue antibiotics
• If new fever develops → Obtain cultures, continue antibiotics, reassess source
• If WBC continues rising or patient deteriorates → Broaden coverage, obtain imaging (chest/abdomen CT), consider fungal coverage if fever >4-6 days 4

Beyond Day 7:

• If still requiring antibiotics → Infectious disease consultation
• Monitor for drug-induced cytopenias with prolonged therapy 7

Common Pitfalls to Avoid

1. Do not reflexively change antibiotics based on leukocytosis alone in an afebrile, stable postoperative patient
2. Do not continue antibiotics indefinitely "just in case"—this increases risk of C. difficile infection and drug toxicity 5, 6, 7
3. Do not attribute all leukocytosis to malignancy in the immediate postoperative period—surgical stress is the most likely explanation 1
4. Do not forget that Piperacillin-Tazobactam can cause hematologic toxicity with prolonged use, though this manifests as cytopenia, not leukocytosis 7, 10, 9